Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Preclinical and preliminary clinical profile of NE-100, a new antipsychotic drug

Dec. 11, 1997

DepoMorphine enters phase II trials

Dec. 10, 1997

Novel nAChR ligands prepared as potential cognitive enhancers

Dec. 10, 1997

Sibia Neurosciences reports promising phase I data for SIB-1508Y

Dec. 10, 1997

CRF antagonists from DuPont Merck for anxiety, depression and related disorders

Dec. 9, 1997

Safe and effective new D2 partial agonist in development at Wyeth-Ayerst

Dec. 9, 1997

Novel valproic acid prodrug reported at scientific meeting

Dec. 9, 1997

New antihyperalgesic agents from Adolor

Dec. 9, 1997

Pfizer improves on NMDA antagonists

Dec. 9, 1997

New muscarinic compound from Wyeth-Ayerst

Dec. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.